Heather Wakelee

[Heather Wakelee @HwakeleeMD]

#TexasLung24 @TLCconference is starting. Had a great networking and mentoring session with @NarjustFlorezMD @karenkellymd Tina Cascone and Jhanelle Gray. @StephenVLiu and Tina Cascone opening Texas style and the first talk by Jhanelle Gray were fabulous!

[Heather Wakelee @HwakeleeMD]

@max_diehn takes the stage #ELCC24 @IASLC @myESMO #ESMOambassadors and gives an outstanding overview of ctDNA to evaluate MRD and ongoing trials including @JoelNealMD ADAPT-E enrolling @StanfordCancer and many other exciting global protocols

[Heather Wakelee @HwakeleeMD]

@myESMO @IASLC #ESMOambassadors it’s a fantastic day 2 of #ELCC24 and in just over an hour the proffered papers are coming with FLAURA2 updates, RATIONALE-315 surgical outcomes, PACIFIC-2 final results and long-term CONVERT outcomes. Quite a line-up! Join us 15:10 Prague time!

[Heather Wakelee @HwakeleeMD]

#ELCC24 Its starting!!! Lots to look forward to in the exciting agenda. @myesmo @iaslc Don’t forgot to make time to enjoy the amazing Prague. #ESMOambassadors

[Heather Wakelee @HwakeleeMD]

@myesmo #iaslc #ESMOambassadors excited for the start of #ELCC24 in Prague! Started the day with breakfast with conference co-chair and IASLC board member #natashaleighl and fellow board member @paugalde20

[Heather Wakelee @HwakeleeMD]

#ESMO23 @myESMO Great presentation by Kathryn Arbour from MSKCC on pan-RAS RMC-6236 with ORR 38% in NSCLC with KRAS G12D, G12V and other non-G12C mutations. Many ongoing responses.

[Heather Wakelee @HwakeleeMD]

#ESMO23 @myESMO Brilliant talks by Tina Cascone and @bensolomon1 with strongly positive data from CM77T and ALINA!! Options for early stage NSCLC keep expanding almost daily. Fabulous discussion by @marinagarassino putting these in perspective. #iaslc #LCSM

[Heather Wakelee @HwakeleeMD]

I am very excited about the positive OS results of KN671 and now FDA approval for peri-operative pembrolizumab in stage II/III NSCLC! Looking forward to @DoctorJSpicer #ESMO2023 presentation! @IASLC #lcsm

[Heather Wakelee @HwakeleeMD]

Fabulous presentation @IASLC #wclc2023 on molecular underpinnings of early stage NSCLC and screening eligibility by @JackieAredoMD

[Heather Wakelee @HwakeleeMD]

Excited to be on the way to Singapore for #wclc2023! Connected up with fellow @iaslc board members @DrRoyHerbstYale @JhanelleGray at SFO

[Heather Wakelee @HwakeleeMD]

Fantastic wrap-up all star panel on the future of oncology #ilcc23 #lcsm Always a fun meeting to co chair with @drgandara @DrRoyHerbstYale with fabulous speakers including @CoreyLangerMD @peters_solange @TonyMok9 and David Carbone! Looking forward to next year!

[Heather Wakelee @HwakeleeMD]

Congratulations to former @IASLC President David Carbone -Winner of the Addario award at #ILCC23 ! #lcsm I am excited to honor him with co-chairs @DrRoyHerbstYale @drgandara and @GO2forLungCancr Chief Patient Officer Danielle Hicks!

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

We are SO excited to have @FunchainMD join us starting next week! Dr Funchain is a prominent leader in skin cancer genetics and irAEs. We are gaining momentum and look forward to enhancing the care of cutaneous oncology patients on the West Coast via clinical trials and translational research!

[Heather Wakelee @HwakeleeMD]

All star panel led by @IASLC CEO Karen Kelly discussing early stage NSCLC management on day 1 of #ILCC23 in Huntington Beach. Lots to debate! @leahbackhusmd @HosseinBorghaei @CoreyLangerMD @DavidCookeMD

[Heather Wakelee @HwakeleeMD]

Great poster discussion review by @JoelNealMD focused on biomarkers in NSCLC #ASCO2023 day 3. ADAURA OS was the big lung cancer news of the day and in addition there were some fantastic posters presented.

[Heather Wakelee @HwakeleeMD]

Great presentation by @NaglaAKarimMD #ASCO2023 on atezolizumab plus talazoparib in SCLC. S1929 positive trial for PFS!

[Heather Wakelee @HwakeleeMD]

@JulieBrahmer @ASCO Such a fantastic group!

[Heather Wakelee @HwakeleeMD]

#ASCO23 day 2! I am honored and excited to present Keynote671 in the CSS starting in 10 minutes!!

[Heather Wakelee @HwakeleeMD]

#ASCO2023 kicks off with EGFR focused CSS including a fantastic talk by @JackieAredoMD on neoadjuvant osimertinib. Lots of exciting lung cancer data ahead in coming days.

[Heather Wakelee @HwakeleeMD]

Congratulations @manalipatelmd ! You are doing Fantastic work!!!

[Steven Artandi, MD, PhD @SCIDirector]

Congratulations to SCI member @manalipatelmd for being recognized as an Advocacy Champion by @ASCO during the May #AscoAdvocacySummitt! Her tireless efforts have contributed to ensuring equitable, high-quality cancer care for all. https://t.co/bVAQwry7O5 #EquitableHealthcare